Results
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
|
|
|
32.
|
Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer. [electronic resource] by
- Goldberg, M R
- Heimbrook, D C
- Russo, P
- Sarosdy, M F
- Greenberg, R E
- Giantonio, B J
- Linehan, W M
- Walther, M
- Fisher, H A
- Messing, E
Producer: 19990209
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 1
Availability: No items available.
|
|
|
33.
|
Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonists. [electronic resource] by
- Heimbrook, D C
- Saari, W S
- Balishin, N L
- Friedman, A
- Moore, K S
- Reimen, M W
- Kiefer, D M
- Rotberg, N S
- Wallen, J W
- Oliff, A
Producer: 19890802
In:
The Journal of biological chemistry vol. 264
Availability: No items available.
|
|
|
34.
|
Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. [electronic resource] by
- Heimbrook, D C
- Stirdivant, S M
- Ahern, J D
- Balishin, N L
- Patrick, D R
- Edwards, G M
- Defeo-Jones, D
- FitzGerald, D J
- Pastan, I
- Oliff, A
Producer: 19900719
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 87
Availability: No items available.
|
|
|
35.
|
|
|
|
36.
|
Biological activity of a transforming growth factor-alpha--Pseudomonas exotoxin fusion protein in vitro and in vivo. [electronic resource] by
- Heimbrook, D C
- Stirdivant, S M
- Ahern, J D
- Balishin, N L
- Patrick, D R
- Edwards, G M
- Defeo-Jones, D
- FitzGerald, D J
- Pastan, I
- Oliff, A
Producer: 19910614
In:
Journal of industrial microbiology vol. 7
Availability: No items available.
|
|
|
37.
|
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. [electronic resource] by
- Jones, R E
- Wegrzyn, R J
- Patrick, D R
- Balishin, N L
- Vuocolo, G A
- Riemen, M W
- Defeo-Jones, D
- Garsky, V M
- Heimbrook, D C
- Oliff, A
Producer: 19900904
In:
The Journal of biological chemistry vol. 265
Availability: No items available.
|
|
|
38.
|
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors. [electronic resource] by
- Huber, H E
- Robinson, R G
- Watkins, A
- Nahas, D D
- Abrams, M T
- Buser, C A
- Lobell, R B
- Patrick, D
- Anthony, N J
- Dinsmore, C J
- Graham, S L
- Hartman, G D
- Lumma, W C
- Williams, T M
- Heimbrook, D C
Producer: 20010809
In:
The Journal of biological chemistry vol. 276
Availability: No items available.
|
|
|
39.
|
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. [electronic resource] by
- Lobell, R B
- Omer, C A
- Abrams, M T
- Bhimnathwala, H G
- Brucker, M J
- Buser, C A
- Davide, J P
- deSolms, S J
- Dinsmore, C J
- Ellis-Hutchings, M S
- Kral, A M
- Liu, D
- Lumma, W C
- Machotka, S V
- Rands, E
- Williams, T M
- Graham, S L
- Hartman, G D
- Oliff, A I
- Heimbrook, D C
- Kohl, N E
Producer: 20020110
In:
Cancer research vol. 61
Availability: No items available.
|
|
|
40.
|
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency. [electronic resource] by
- Bell, I M
- Gallicchio, S N
- Abrams, M
- Beshore, D C
- Buser, C A
- Culberson, J C
- Davide, J
- Ellis-Hutchings, M
- Fernandes, C
- Gibbs, J B
- Graham, S L
- Hartman, G D
- Heimbrook, D C
- Homnick, C F
- Huff, J R
- Kassahun, K
- Koblan, K S
- Kohl, N E
- Lobell, R B
- Lynch, J J
- Miller, P A
- Omer, C A
- Rodrigues, A D
- Walsh, E S
- Williams, T M
Producer: 20010927
In:
Journal of medicinal chemistry vol. 44
Availability: No items available.
|